<?xml version="1.0" encoding="UTF-8"?>
<p id="para10">When WHO added Disease X to its 
 <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/blue-print/2018-annual-review-of-diseases-prioritized-under-the-research-and-development-blueprint.pdf?sfvrsn=4c22e36_2" id="interrefs10" xmlns:xlink="http://www.w3.org/1999/xlink">R&amp;D Blueprint</ext-link> in 2018, the reality of an unknown pathogen that could cause a serious international epidemic was just beyond the limits of the imagination. 2 years later, at the time of writing this Editorial—the beginning of April, 2020—over 1 million people around the world have been infected with COVID-19 virus and 80 000 people have died from the disease. One-third of the world's population is in lockdown. As the world's most advanced economies struggle to repurpose state and private sector capacity to meet the growing demands on health services, the spotlight is shifting to countries without formal social safety nets or the massive monetary injections needed to bolster their economies.
</p>
